Osteofibrous dysplasia is a rare, noncancerous bone condition that usually affects the shin bone in children and teenagers. The early symptoms of osteofibrous dysplasia often include a painless or mildly painful swelling, a bowing of the lower leg, or a limp. Not everyone will have the same experience. Osteofibrous dysplasia often grows slowly and may become less active after puberty, and it is not usually life-threatening. Treatment may involve monitoring, bracing, or surgery when the bone is weak, the leg is more bent, or walking is affected.
How many people live with Osteofibrous dysplasia?
Osteofibrous dysplasia is very rare, but there is no widely accepted estimate for how many people are living with it worldwide or in the United States. Published rare disease sources do not consistently report a global or U.S. total for this condition.
Overview
Osteofibrous dysplasiaSymptoms
Osteofibrous dysplasia often affects the shinbone, causing a visible bowing of the lower leg. Many people have mild pain, swelling, or a limp. In children, it may also lead to a small fracture after minor injury.
Outlook and prognosis
Osteofibrous dysplasia often grows slowly and may stabilize after puberty, so many people do well with monitoring. When it affects walking, causes pain, or weakens a bone, treatment can help protect function and lower the chance of repeat problems.
Causes and risk factors
In osteofibrous dysplasia, the exact cause is unclear, but it likely begins early in bone development. It is most often seen in children, especially in the shinbone or nearby fibula. Lifestyle or environmental risk factors are not known.
Genetic influences
For osteofibrous dysplasia, genetics do not seem to play a major role in most cases. It is usually not inherited, and no single gene change has been clearly linked to osteofibrous dysplasia.
Diagnosis
Diagnosis of Osteofibrous dysplasia usually starts with symptoms, an exam, and imaging findings on X-rays, CT, or MRI. Doctors may confirm Osteofibrous dysplasia with a bone biopsy to rule out similar conditions.
Treatment and drugs
Osteofibrous dysplasia is often managed with regular checkups and imaging to watch how the bone changes over time. Bracing may help some children. Surgery is usually reserved for pain, fractures, or trouble walking.
Symptoms
Many children with Osteofibrous dysplasia feel well and stay active, but a firm swelling or curved lower leg may become noticeable over time. The early features of Osteofibrous dysplasia can be subtle, and features can vary from person to person as a child grows. The changes usually affect the shinbone, sometimes the nearby smaller bone, and often involve just one leg. Pain is often mild or absent, but some children develop limping or fractures.
A firm bump or thickened area over the front of the shin is a common sign. It often grows slowly and may be noticed during bathing, dressing, or sports.
The lower leg may curve forward or outward instead of looking straight. For many, this can mean the legs look uneven when standing or walking.
Many children have little or no pain, especially at first. When discomfort happens, it is often mild and may be more noticeable after running, jumping, or a knock to the leg.
If the bone is bowed, sore, or weaker than usual, walking can look uneven. Some children may tire sooner with play or avoid putting full weight on that leg.
How people usually first notice Osteofibrous dysplasia?
Osteofibrous dysplasia is often first noticed in infancy or early childhood, when a parent or doctor sees a painless bowing of the lower leg, usually the shin, or feels a firm swelling over the bone. For many living with osteofibrous dysplasia, the first signs can also include one leg looking slightly more curved than the other, a limp, or repeated concern after an X-ray is done for leg shape, pain, or a minor injury. Although the appearance can be worrying, this condition is usually slow-growing and benign, and the next step is typically imaging and evaluation by a bone specialist to confirm what is causing the change.
Types of Osteofibrous dysplasia
Osteofibrous dysplasia does not have clearly established disease subtypes in the way some genetic or metabolic conditions do. Symptoms don’t always look the same for everyone. Instead, differences usually reflect where the bone lesion is, how large it is, and whether it causes bowing, pain, or a fracture. In other words, no distinct types of osteofibrous dysplasia are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes, diet, supplements, or exercise can meaningfully delay when symptoms begin in osteofibrous dysplasia; it is a rare bone growth problem that usually starts in childhood and is not known to be preventable. Regular checkups with a bone specialist can help catch leg bowing, pain, or small breaks early and guide monitoring, bracing, or surgery when needed, but this manages problems after they appear rather than preventing the condition itself. While research on rare bone conditions is ongoing, careful follow-up can still make a real difference in day-to-day comfort and function.
What genetics can tell you about symptoms
For people with osteofibrous dysplasia, genetics usually cannot tell much about which symptoms will happen, how severe they will be, or when they will start. This condition is not usually inherited, and there is no well-established gene change that doctors use to predict whether someone will have mild shin pain, a visible bowing of the lower leg, or repeated fractures. In most cases, symptoms are guided more by which bone is affected and how much of it is involved than by a known genetic pattern.
Causes and risk factors
Osteofibrous dysplasia seems to happen when bone in the lower leg does not grow in the usual way during childhood. Doctors do not know the exact cause, and it is not usually linked to an inherited gene change. The main biological risk factors for osteofibrous dysplasia are young age, usually in childhood, and male sex may raise the chance a little. No clear lifestyle risks, such as diet, exercise, or sports, have been proven, and there is no strong evidence that common environmental exposures cause it. Researchers are still learning how these pieces fit together, including why the causes of osteofibrous dysplasia usually involve the shinbone and sometimes the nearby smaller leg bone.
What are the most common causes or risk factors?
The exact cause of osteofibrous dysplasia is not known. It most often develops in children, especially in the shin bone and sometimes the smaller bone next to it, so young age is the main known risk factor; boys may be affected slightly more often than girls. It usually happens by chance rather than running in families, and there is no strong evidence that lifestyle, diet, or a past injury causes it.
Environmental and biological risk factors
For osteofibrous dysplasia, the known risk factors are limited and appear to be mostly biological rather than environmental. It is seen mainly during the years when leg bones are still growing, and many living with osteofibrous dysplasia have no clear outside exposure linked to it. Researchers are still exploring how outside influences interact with our inner biology.
Osteofibrous dysplasia is found most often in infants, children, and young teens, which points to active bone growth as an important biological factor. It is much less common for it to first appear in adults.
Some reports suggest osteofibrous dysplasia may be slightly more common in boys than girls. This difference is small, so sex alone does not strongly predict who will develop it.
The condition usually develops in the tibia and sometimes the fibula while these bones are still maturing. This pattern suggests that local growth processes in the lower leg are part of the biological risk.
No specific environmental trigger, such as an infection, toxin, radiation exposure, or minor injury, has been clearly shown to cause osteofibrous dysplasia. Plenty of people with similar exposures live without developing the condition.
Genetic risk factors
For many families, the biggest question is whether osteofibrous dysplasia runs in the family. In most people, it does not seem to be inherited, and the genetic causes of osteofibrous dysplasia are still not fully understood. Researchers think it usually starts from changes that arise only in the affected bone rather than from a gene passed down through the family.
Sporadic cases: Most osteofibrous dysplasia cases happen sporadically, meaning they appear without a known inherited cause. Family history is uncommon in people with this condition.
Inherited pattern: Doctors have not found a single gene change that clearly causes osteofibrous dysplasia in most people. A consistent inheritance pattern, such as dominant or recessive inheritance, has not been established.
Bone-only changes: Research suggests some genetic changes may develop only in the abnormal bone tissue as it grows. These changes are usually thought to be local rather than present in every cell of the body.
Adamantinoma overlap: Osteofibrous dysplasia can share some genetic and tissue features with a related bone tumor called adamantinoma. This may help explain why the two conditions can look similar under the microscope, although osteofibrous dysplasia is usually a separate, benign condition.
Family risk: Because the disorder is usually not inherited, close relatives are not thought to have a high genetic risk. Genetic testing is not routinely needed unless there are other unusual findings that suggest a broader hereditary condition.
Lifestyle risk factors
Osteofibrous dysplasia is not caused by lifestyle habits, but day-to-day choices can influence pain, fracture risk, mobility, and recovery from treatment. Because it affects bone strength most often in the lower leg, activities and health habits that change mechanical stress on the tibia matter more than they would for many other conditions. When people ask about lifestyle risk factors for Osteofibrous dysplasia, the main issue is not who develops it, but how lifestyle affects Osteofibrous dysplasia symptoms and complications over time.
Repeated jumping, contact sports, or heavy loading through the affected leg can increase pain and raise the chance of stress injury or fracture in weakened bone. Activity often needs to be adjusted to the bone’s stability and the advice of the treating orthopedic team.
Too little movement can reduce muscle strength, joint support, and balance, which may worsen gait problems and make everyday function harder. Low-impact exercise guided by clinicians may help maintain mobility without overstressing the affected bone.
Higher body weight increases force across the tibia and can add to pain, limping, and mechanical strain in a bone already altered by osteofibrous dysplasia. Weight management, when needed, may help reduce symptoms and improve tolerance of walking and rehabilitation.
Inadequate intake of protein, calcium, vitamin D, and overall calories can impair bone health and slow healing after fractures or surgery. Good nutrition does not cure the lesion, but it may support stronger recovery and better musculoskeletal function.
Risk prevention
Osteofibrous dysplasia cannot usually be prevented, because it is a rare bone condition that develops as a child grows rather than from something a family did or did not do. For many living with osteofibrous dysplasia, prevention means lowering the chance of problems such as pain, bowing of the leg, or a fracture, especially during active growth years. Prevention is about lowering risk, not eliminating it completely. Regular follow-up is often the best way to catch changes early and decide when support, activity changes, or treatment may help.
Checkups with an orthopedic specialist can help track how osteofibrous dysplasia is affecting bone growth over time. X-rays or other imaging may be used to look for worsening bowing, thinning bone, or changes that raise fracture risk.
Avoiding high-impact activities after pain, limping, or a stress injury can help reduce the chance of a break in a weakened shin bone. Many with osteofibrous dysplasia do better with lower-impact exercise that keeps them active without overloading the leg.
Paying attention to early symptoms of osteofibrous dysplasia, such as shin pain, a new limp, or increasing leg bowing, can help families seek care before complications build. Small changes can matter when a child is still growing.
In some children, a brace may help support the leg and reduce strain on bone affected by osteofibrous dysplasia. This can be especially useful if bowing is getting worse or walking becomes uncomfortable.
Can you prevent Osteofibrous dysplasia?
No, there is no known way to prevent osteofibrous dysplasia. It is a rare bone condition that usually starts during childhood, and it has not been clearly linked to diet, exercise, injuries, or other everyday habits. While prevention is not currently possible, getting checked if a child has leg pain, limping, or a bowed lower leg can help with early care.
Transmission
Osteofibrous dysplasia is not infectious, so it cannot be spread from one person to another through touch, coughing, sex, blood, or everyday contact. Many living with osteofibrous dysplasia can be reassured that it does not “catch” or pass through a household, school, or workplace.
When people ask about how osteofibrous dysplasia is inherited, the key point is that it is usually not passed from parent to child. The exact cause is not fully understood, but most cases appear to happen sporadically rather than through genetic transmission of osteofibrous dysplasia.
When to test your genes
For osteofibrous dysplasia, genetic testing is not usually part of early detection or routine care because the diagnosis is typically made from symptoms, imaging, and sometimes biopsy. Testing may be considered only if the bone changes look unusual or if doctors suspect a different inherited bone condition.
Diagnosis
Osteofibrous dysplasia is often suspected when a child or teen has a painless bowing of the lower leg, a firm bump over the shin, or repeated pain after activity. The diagnosis of osteofibrous dysplasia usually starts with the symptoms, the way the bone looks on exam, and imaging of the tibia, which is the shin bone. Some diagnoses are clear after a single visit, while others take more time.
Doctors ask about leg pain, limping, swelling, bowing, and any fractures or trouble with activity. A detailed family and health history can help rule out other bone conditions and show when the changes first appeared.
The clinician checks the shape of the lower leg, tenderness, and whether one area of the shin feels enlarged or bowed. They also look at walking, leg length, and nearby joints to see how much the bone change is affecting daily movement.
Standard X-rays are the main test because osteofibrous dysplasia often has a typical look in the outer part of the shin bone. Doctors look for a well-defined area with thinning and expansion of the bone cortex, which can help separate it from more aggressive bone problems.
Your provider may suggest CT or MRI to look closer if the X-ray findings are unclear or surgery is being considered. These scans show how much of the bone is involved and whether the lesion extends deeper than expected.
How is Osteofibrous dysplasia diagnosed?
Osteofibrous dysplasia is usually diagnosed with a doctor’s exam and imaging tests, especially X-rays, which often show a typical pattern in the shin bone and sometimes the smaller bone next to it. If the pictures are not clear or doctors need to make sure it is not another bone problem, they may order an MRI or CT scan and sometimes take a small sample of bone to look at under a microscope. Genetic testing is not usually needed to diagnose it.
Stages of Osteofibrous dysplasia
Osteofibrous dysplasia does not have defined progression stages. This is because it is usually described by how the bone lesion looks, where it is, and whether it is causing symptoms, rather than by a step-by-step decline over time. Doctors usually start with a conversation about pain, limping, or swelling, and imaging tests such as X-rays are often used to check the affected bone and look for features linked to the early symptoms of osteofibrous dysplasia. In some cases, especially when the findings are unclear, a biopsy and follow-up scans over time may be used to confirm osteofibrous dysplasia and monitor for changes as a child grows.
Outlook and prognosis
The outlook for osteofibrous dysplasia is generally very good, as it is a benign bone lesion that often stabilizes or improves after skeletal maturity. Many children can be managed with observation alone, especially when symptoms are mild and the tibia remains structurally stable. The main concerns are bowing of the affected bone, pain, or pathologic fracture, and some patients need surgery if deformity progresses or function is limited. Recurrence after surgery can occur, particularly if an operation is done at a young age before growth is complete. Life expectancy is typically normal, and osteofibrous dysplasia is not usually associated with increased mortality. Careful long-term follow-up is important because imaging and biopsy may be needed to distinguish it from related lesions such as adamantinoma.
Long-term effects
Osteofibrous dysplasia mainly affects the shin bone, and over time it can change how the lower leg looks and works. Many living with osteofibrous dysplasia have a stable course, but some continue to have bowing, pain, or trouble with repeated stress on the bone. It’s important to remember that long-term doesn’t always mean progressive. The long-term effects of osteofibrous dysplasia often depend on how much of the bone is involved and whether the condition settles after growth slows.
The most common long-term effect is bowing of the lower leg, especially in the tibia. For many, this can mean one leg looks curved or seems less steady when standing or walking.
Weakened areas in the bone can raise the chance of stress fractures or full breaks over time. This may show up as new pain after running, jumping, or even a minor bump.
Some people with osteofibrous dysplasia continue to have aching in the shin, especially with activity. Pain is often mild to moderate, but it can limit sports, long walks, or jobs that involve a lot of standing.
If the bone stays bowed or heals unevenly, gait can change over time. Many people notice small adjustments like limping, turning the foot outward, or tiring faster with longer distances.
How is it to live with Osteofibrous dysplasia?
Living with osteofibrous dysplasia can mean dealing with ongoing shin pain, a visible bowing of the lower leg, or a limp that makes running, sports, and long walks harder than expected, especially in childhood. Many people with this condition need regular checkups and imaging to watch how the bone is growing, and some may need activity changes, bracing, or surgery if the bone becomes weak or fractures. For families, daily life can involve extra appointments, worry about falls or pain flare-ups, and practical adjustments at school or during play, but with good orthopedic care, many children and adults are able to stay active and do well.
Treatment and drugs
Treatment for osteofibrous dysplasia often depends on age, symptoms, and how much the bone is affected. Many children with osteofibrous dysplasia are watched over time with regular checkups and imaging, because the condition can grow more slowly or settle after puberty if it is not causing major pain, bowing, or fractures. Finding the right therapy can take some time, and surgery is usually saved for problems such as a curved lower leg, trouble walking, repeated fractures, or when doctors need to be sure of the diagnosis; operations may involve removing the abnormal area and rebuilding or straightening the bone. There is no medicine that cures osteofibrous dysplasia itself, but pain relievers may help symptoms, and treatment is usually planned with an orthopedic specialist who can explain the benefits and the chance that the problem can come back, especially if surgery is done early in childhood.
Can you cure Osteofibrous dysplasia?
There is no simple cure for osteofibrous dysplasia, but many cases become more stable as a child gets older. Treatment is meant to manage the condition by checking the bone over time, easing pain, protecting the leg, and, if needed, using surgery to fix bowing or breaks in the bone.
Non-drug treatment
Living with osteofibrous dysplasia often means dealing with shin pain, a limp, or worry about a bone that seems easy to bend or break during everyday play and sports. Treatment is usually centered on watching the bone closely, protecting it from stress, and using surgery only when symptoms, deformity, or repeat fractures make it necessary. Not every approach works the same way, especially because treatment for osteofibrous dysplasia in children may differ from care in teens or adults.
Regular follow-up visits and imaging are often the first step when symptoms are mild and the bone is stable. This helps your care team watch for growth changes, worsening bowing, or signs that the lesion is becoming more troublesome.
Cutting back on high-impact sports or repeated jumping can lower stress on a weakened shin bone. For many, this can mean choosing swimming, cycling, or other lower-impact activities while the bone is healing or being monitored.
A brace or supportive splint may help protect the leg if the bone is bowed or at risk of fracture. Some may find it makes walking feel steadier and reduces pain during daily activities.
Physical therapy can help improve strength, balance, and walking pattern when pain or limping has changed how someone moves. Structured programs, like gait training and muscle strengthening, can help the leg work more efficiently without overloading the bone.
Your genes may have an impact on how drugs work for you
For osteofibrous dysplasia, treatment usually centers more on monitoring, pain relief, and sometimes surgery than on long-term disease-specific medicine, so genetic testing to guide medication choice is not a routine part of care. Still, inherited differences can affect how some people break down common medicines such as pain relievers or drugs used during surgery, which may change how well a medicine works or how likely side effects are. If pain control has been hard to manage, or if there is a history of unusual reactions to medicines in your family, it is worth asking the care team whether this could matter for treatment.
Pharmacological treatments
For many living with osteofibrous dysplasia, medicines are not the main treatment because drugs do not remove the bone lesion itself. When medication is used, it is usually to ease pain, help around a procedure, or treat a complication such as infection. This means medications for osteofibrous dysplasia are often supportive rather than disease-specific.
Acetaminophen and anti-inflammatory drugs such as ibuprofen or naproxen may help with leg pain or soreness from osteofibrous dysplasia. These medicines can make walking, sports, or standing at school or work more comfortable, but they do not shrink the abnormal bone area.
If surgery is needed, doctors may use anesthetic drugs during the procedure and short-term pain medicines afterward. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy).
Antibiotics are not a routine treatment for osteofibrous dysplasia itself, but they may be used if there is a wound infection after surgery or another clear bacterial infection. The exact drug depends on the suspected germ, the person's age, and how severe the infection is.
There is no widely accepted medicine that reliably treats the underlying bone changes in osteofibrous dysplasia. Drugs used for other bone conditions, such as bisphosphonates, are not standard care here and are usually not the first approach.
Genetic influences
When osteofibrous dysplasia affects a child’s shin bone, families often wonder whether siblings or future children could face the same problem. For most people with osteofibrous dysplasia, there is no clear inherited cause, and it usually seems to arise on its own during bone growth rather than being passed down through generations. It’s natural to ask whether family history plays a role, but family clustering has not been clearly established for osteofibrous dysplasia. Researchers have looked for genetic causes of osteofibrous dysplasia, yet no single gene change has been confirmed as the usual cause, so genetic testing is not a routine part of diagnosis. Instead, doctors usually rely on imaging, the child’s age, and sometimes a small tissue sample to tell it apart from other bone conditions. In practical terms, this means most families do not need to assume a strong inherited risk, though a specialist can help if the diagnosis is uncertain or if there is an unusual family history.
Is Osteofibrous dysplasia genetic?
For osteofibrous dysplasia, genetics do not seem to play a major role in most cases. It is usually not inherited, and no single gene change has been clearly linked to osteofibrous dysplasia.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct impact on health and simply reflect the natural differences seen among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with osteofibrous dysplasia, treatment decisions usually depend more on pain, bowing of the leg, and how the bone is growing than on a genetic test. Unlike some conditions where doctors use gene results to pick a drug or dose, osteofibrous dysplasia does not currently have a standard gene-guided medicine, so pharmacogenetic testing is not usually part of care. When medicine is used, it is most often for symptom relief, such as pain control, and doctors choose it based mainly on age, other health conditions, and how well it works rather than on a known osteofibrous dysplasia gene pattern. In some cases, testing of a bone sample may be needed to help tell osteofibrous dysplasia apart from related bone tumors, and that can affect whether monitoring, bracing, or surgery is the better plan. Genetics is only one factor, and in osteofibrous dysplasia it often plays a smaller role in treatment than the bone’s appearance on scans and the stage of growth. If you are asking about the best treatment for osteofibrous dysplasia, it is often more helpful to ask whether the diagnosis is fully confirmed than to expect genetics to guide the medications used for osteofibrous dysplasia.
Interactions with other conditions
Many living with osteofibrous dysplasia mainly deal with bowing of the lower leg, pain, or a limp, but one important concern is how it can overlap in appearance with other bone conditions. Another important aspect is how it may link with other diseases. On scans and even under the microscope, osteofibrous dysplasia can sometimes look similar to adamantinoma, a rare bone tumor that also tends to affect the shinbone, so doctors are careful to tell these apart. It can also be confused with fibrous dysplasia, which is a different bone disorder and usually behaves differently over time. For many, this means the biggest “interaction” is not that osteofibrous dysplasia causes other illnesses, but that it may need follow-up with imaging and sometimes repeat biopsy if the diagnosis is uncertain. If symptoms change, the bone weakens more quickly, or early symptoms of osteofibrous dysplasia seem to be getting worse than expected, doctors may reassess to rule out another bone disease rather than assume it is all from the same condition.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Osteofibrous dysplasia?
Conditions that can look similar to osteofibrous dysplasia include fibrous dysplasia, which is another bone problem that can weaken and bend bone, and adamantinoma, a rare bone tumor that often affects the shin in a similar way. Stress fractures, ongoing bone infection, and some noncancerous bone growths can also cause shin pain, swelling, bowing, or repeated fractures, so doctors may need imaging and sometimes a biopsy to tell them apart.
History
Many living with osteofibrous dysplasia first hear about it after a child develops a painless bowing of the lower leg, or an X-ray done for a limp shows an unusual area in the shin bone. Although it can feel surprising to get such a specific diagnosis, doctors have been recognizing this pattern for quite a long time. First described in the medical literature as a distinct bone condition in the 20th century, osteofibrous dysplasia gradually became better understood as imaging and bone pathology improved.
Earlier on, doctors did not always agree on where osteofibrous dysplasia fit among other bone disorders. Some cases were grouped with fibrous bone conditions more broadly, while others were confused with more serious diseases that can affect the tibia, the larger bone in the lower leg. Over time, careful follow-up of children and teens showed that osteofibrous dysplasia often has a characteristic pattern: it usually affects the shin, tends to appear early in life, and may change as a child grows.
As medical science evolved, specialists learned more about how osteofibrous dysplasia behaves over time. This helped doctors move away from older, less precise labels and improve the way they diagnose it, often using a mix of exam findings, imaging, and sometimes a biopsy when the picture is not clear. Researchers later identified that there is a genetic basis in related bone conditions, which also helped refine how osteofibrous dysplasia is classified, even though its exact relationship to similar disorders has been studied carefully for years.
Today, the history of osteofibrous dysplasia matters because it explains why diagnosis can sometimes take time and why expert review is important. Awareness of past misunderstandings can help families make sense of why doctors may recommend monitoring rather than rushing into treatment, especially when the main concern is leg shape, walking comfort, or the risk of fracture rather than pain alone.